{
 "as_of": "2026-11-06",
 "cmr": "au-cm-kg/ASX/NSB",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD (ASX: NSB) — research page\n\nAs of 2026-11-06 · au-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD, listed on the ASX under ticker NSB. Its ISIN is AU0000012973 and its LEI is 254900YGHQSAMJODKC85. Its security type is Corporate, its segment is not on the record, its sector is Health Care, and its jurisdiction is Australia (ASIC-registered public company). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 35 filings in the twelve months from 2025-11-06 to 2026-11-06, across 30 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-10-28, is of type corporate_action, and was 9 days before the record date of 2026-11-06. The ASX median is 6 days between filing days, 58 filings, and 4.0 days of latency. The Health Care median is 5.0 days between filing days, 65 filings, and 7 days of latency. The issuer's filing count of 35 is below the ASX median of 58 and below the Health Care median of 65.\n\n## Auditor\n\nThe auditor of record is not on the record. The record carries the annual report link only, which is a source link and not a read. The auditor's location is not on the record, and auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because the market has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.\n\n## Orderability\n\nThe outcome cannot be determined. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/au/ddo-design-and-distribution-obligations/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's own investor-relations page.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.asx.com.au/markets/trade-our-cash-market/directory (identity.exchange)\n- https://www.asx.com.au/markets/company/NSB (identity.isin)\n- https://data.gov.au/data/dataset/asic-companies (identity.jurisdiction)\n- https://api.gleif.org/api/v1/lei-records/254900YGHQSAMJODKC85 (identity.lei)\n- https://mcp.au-cm-kg.ai/events/ASX/NSB (the disclosure lines)\n- https://asx.api.markitdigital.com/asx-research/1.0/markets/announcements ; https://www.nsx.com.au/marketdata/delisted-suspended/ (the halt flag)\n- https://mcp.au-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.au-cm-kg.ai/record/ASX/NSB (the record)\n",
 "market": "AU",
 "node": "au-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the AU vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "AU",
    "reason": "Width 0 records the annual report link only (ORDER-010: source link, not a read)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "AU",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "AU",
    "state": "not_on_record"
   },
   "changes": {
    "market": "AU",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "au-cm-kg/ASX/NSB",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 1829,
     "median_cadence_gap_days": 6,
     "median_filings": 58,
     "median_latency_days": 4,
     "name": "ASX"
    },
    "sector": {
     "issuers": 163,
     "median_cadence_gap_days": 5,
     "median_filings": 65,
     "median_latency_days": 7,
     "name": "Health Care"
    }
   },
   "by_type": {
    "agm_record_date": 4,
    "asx_announcement": 18,
    "corporate_action": 2,
    "director_interest": 1,
    "financial_statement": 2,
    "halt_resume": 2,
    "quarterly": 4,
    "substantial_holder": 2
   },
   "cadence_median_gap_days": 7,
   "filing_days": 30,
   "filings": 35,
   "latency_days": 9,
   "latest": [
    {
     "category": null,
     "date": "2026-10-28",
     "source": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=03158248",
     "title": "Name Change to Miro Sciences (MSX)",
     "type": "corporate_action"
    },
    {
     "category": null,
     "date": "2026-10-27",
     "source": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=03157545",
     "title": "Quarterly Activities/Appendix 4C Cash Flow Report",
     "type": "quarterly"
    },
    {
     "category": null,
     "date": "2026-10-22",
     "source": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=03155620",
     "title": "Appointment of CFO",
     "type": "asx_announcement"
    },
    {
     "category": null,
     "date": "2026-10-15",
     "source": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=03152881",
     "title": "Results of Annual General Meeting",
     "type": "agm_record_date"
    },
    {
     "category": null,
     "date": "2026-10-13",
     "source": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=03151572",
     "title": "US FDA Provides Positive Feedback on Planned Phase 2 Trial",
     "type": "asx_announcement"
    }
   ],
   "latest_filing_date": "2026-10-28",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.au-cm-kg.ai/events/ASX/NSB",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "ASX listed-companies directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.asx.com.au/markets/trade-our-cash-market/directory (directory file asx.api.markitdigital.com/asx-research/1.0/companies/directory/file)",
    "state": "sourced",
    "value": "ASX"
   },
   "isin": {
    "read_by": "ASX company record (exchange site, asx.com.au company page data)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.asx.com.au/markets/company/NSB",
    "state": "sourced",
    "value": "AU0000012973"
   },
   "jurisdiction": {
    "read_by": "ASIC company register bulk dataset (data.gov.au, weekly) (company type)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://data.gov.au/data/dataset/asic-companies (COMPANY_202609.csv)",
    "state": "sourced",
    "value": "Australia (ASIC-registered public company)"
   },
   "lei": {
    "read_by": "GLEIF name-exact",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/254900YGHQSAMJODKC85",
    "state": "filled",
    "value": "254900YGHQSAMJODKC85"
   },
   "name": {
    "read_by": "ASX listed-companies directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.asx.com.au/markets/trade-our-cash-market/directory (directory file asx.api.markitdigital.com/asx-research/1.0/companies/directory/file)",
    "state": "sourced",
    "value": "NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD"
   },
   "sector": {
    "read_by": "ASX company record (exchange site, asx.com.au company page data)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.asx.com.au/markets/company/NSB",
    "state": "sourced",
    "value": "Health Care"
   },
   "security_type": {
    "read_by": "ASX listed-companies directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.asx.com.au/markets/trade-our-cash-market/directory (directory file asx.api.markitdigital.com/asx-research/1.0/companies/directory/file)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "AU",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "ASX listed-companies directory (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.asx.com.au/markets/trade-our-cash-market/directory (directory file asx.api.markitdigital.com/asx-research/1.0/companies/directory/file)",
    "state": "sourced",
    "value": "NSB"
   },
   "website": {
    "market": "AU",
    "reason": "no source read",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "AU",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "AU",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "AU",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "AU",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "AU",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "AU",
  "node": "au-cm-kg",
  "numbers_hash": "sha256:490a4230cf16fa66dbb0a704d396143da793a6366d4427f060b3347e5a7814c7",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.au-cm-kg.ai/book/aio.json",
    "door": "https://mcp.au-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/au/ddo-design-and-distribution-obligations/r1",
   "section": "au.aio.v8"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.au-cm-kg.ai/record/ASX/NSB",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://asx.api.markitdigital.com/asx-research/1.0/markets/announcements ; https://www.nsx.com.au/marketdata/delisted-suspended/",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:490a4230cf16fa66dbb0a704d396143da793a6366d4427f060b3347e5a7814c7",
 "path": "/au/ASX/NSB",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD, listed on the ASX under ticker NSB. Its ISIN is AU0000012973 and its LEI is 254900YGHQSAMJODKC85. Its security type is Corporate, its segment is not on the record, its sector is Health Care, and its jurisdiction is Australia (ASIC-registered public company). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 35 filings in the twelve months from 2025-11-06 to 2026-11-06, across 30 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-10-28, is of type corporate_action, and was 9 days before the record date of 2026-11-06. The ASX median is 6 days between filing days, 58 filings, and 4.0 days of latency. The Health Care median is 5.0 days between filing days, 65 filings, and 7 days of latency. The issuer's filing count of 35 is below the ASX median of 58 and below the Health Care median of 65.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record. The record carries the annual report link only, which is a source link and not a read. The auditor's location is not on the record, and auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because the market has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome cannot be determined. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/au/ddo-design-and-distribution-obligations/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's own investor-relations page.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.asx.com.au/markets/trade-our-cash-market/directory"
  },
  {
   "for": "identity.isin",
   "source": "https://www.asx.com.au/markets/company/NSB"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.gov.au/data/dataset/asic-companies"
  },
  {
   "for": "identity.lei",
   "source": "https://api.gleif.org/api/v1/lei-records/254900YGHQSAMJODKC85"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.au-cm-kg.ai/events/ASX/NSB"
  },
  {
   "for": "the halt flag",
   "source": "https://asx.api.markitdigital.com/asx-research/1.0/markets/announcements ; https://www.nsx.com.au/marketdata/delisted-suspended/"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.au-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.au-cm-kg.ai/record/ASX/NSB"
  }
 ],
 "title": "NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD (NSB) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}